Legal & General UCITS ETF PLC - L&G Healthcare Breakthrough UCITS ETF AccumUSD

HEAL

DOCT

The rise in life expectancy is outpacing the increase in healthy life years, creating a significant gap that presents investment opportunities in healthcare. Bellevue Asset Management emphasizes longevity in its strategies, focusing on healthspan as a key economic variable. Key investment drivers include prevention through digital health monitoring, minimally invasive interventions, and targeted treatments for age-related diseases. The Bellevue Healthcare ETF targets companies that improve clinical outcomes and reduce healthcare costs, aiming to capitalize on the longevity trend in the healthcare market.

FiNews

iShares Healthcare Innovation UCITS ETF

Abbott Laboratories

DexCom

IRhythm

Stryker

Intuitive Surgical

Novo Nordisk AS

Eli Lilly

Amgen

Biogen

Eisai Co., Ltd.

Merck

AstraZeneca

AstraZeneca PLC

Longevity: Where Medical Progress Creates Economic Value

LGEN

Legal & General Group insider Ric Lewis purchased 931 shares at GBX 253 each, totaling £2,355.43. This follows previous acquisitions of 851 and 856 shares at higher prices. The stock rose 1.3% to GBX 254.90, with a market cap of £14.31 billion. Analysts predict an EPS of 24.24 for the fiscal year, and the company has initiated a share buyback program, indicating confidence in its stock value. Positive sentiment surrounds the firm due to insider buying and favorable analyst ratings, including a "buy" from Berenberg with a target of GBX 308.

Market Beat

Legal & General Group Plc

ROYAL BANK OF CANADA

Citigroup

Goldman Sachs

CITIGROUP INC 6.250 NON CUM SER II PFD WI

GS Hldg R

Legal & General Group (LON:LGEN) Insider Ric Lewis Purchases 931 Shares

Legal & General confirms vesting of equity awards for asset management CEO Eric Adler

Tip Ranks

Legal & General confirms vesting of equity awards for asset management CEO Eric Adler

Legal & General Cancels 5.8 Million Shares in Latest Buyback Tranche

Legal & General Cancels 5.8 Million Shares in Latest Buyback Tranche

Legal & General Executives Buy Shares Under Employee Plan

Legal & General Executives Buy Shares Under Employee Plan

Legal & General Admits New Shares Under Employee SAYE Scheme

Legal & General Admits New Shares Under Employee SAYE Scheme

Legal & General updates share capital and voting rights after share buyback

Legal & General updates share capital and voting rights after share buyback

Legal & General discloses share sale by chief risk officer

Legal & General discloses share sale by chief risk officer

In a report released today, from Citi maintained a Hold rating on Legal & General, with a price target of £2.49.Claim 30% Off TipRanks PremiumUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential In addition to Citi, Legal & General also received a Hold from UBS’s Nasib Ahmed in a report issued on March 20. However, yesterday, RBC Capital maintained a Sell rating on Legal & General (LSE: LGEN).

Citi Reaffirms Their Hold Rating on Legal & General (LGEN)

Legal & General UCITS ETF PLC - L&G Healthcare Breakthrough UCITS ETF AccumUSD(DOCT.UK)

Longevity: Where Medical Progress Creates Economic Value

Legal & General Group (LON:LGEN) Insider Ric Lewis Purchases 931 Shares

Legal & General confirms vesting of equity awards for asset management CEO Eric Adler

Legal & General Cancels 5.8 Million Shares in Latest Buyback Tranche

Legal & General Executives Buy Shares Under Employee Plan

Legal & General Admits New Shares Under Employee SAYE Scheme

Legal & General updates share capital and voting rights after share buyback

Legal & General discloses share sale by chief risk officer

Citi Reaffirms Their Hold Rating on Legal & General (LGEN)